Background illustration for clinical trials search

Paid Clinical Trials Maryland

Discover 2,427 paid clinical trials in Maryland. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

for
Advanced Solid Malignancies, Non-small Cell Lung Cancer (NSCLC),
Location: Baltimore MD, Fairfax VA, Toronto, San Antonio TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07223047

Phase1, Phase2, Recruiting

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

for
Type 2 Diabetes, Cortisol Excess
Location: Springfield MA, West Chester PA, Morehead City NC,
Sponsor: Sparrow Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07296484

Phase2, Recruiting

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

for
Gastrointestinal Neoplasms
Location: Boston MA, New Haven CT, Calgary, New Hyde Park NY,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07218926

Phase3, Recruiting

Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty

for
Prosthetic-joint Infection
Location: Boston MA, Baltimore MD, Leland NC, Tamarac FL,
Sponsor: Peptilogics

Sex: All

Age: 18 - 70+

Code: NCT07214311

Phase2, Phase3, Recruiting

Ketorolac Effects on Post-operative Pain and Lumbar Fusion

for
Lumbar Spinal Fusion
Location: Towson MD
Sponsor: University of Maryland St. Joseph Medical Center

Sex: All

Age: 18 - 70+

Code: NCT06513208

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Philadelphia PA, Wilmington DE, Baltimore MD, Miami FL,
Sponsor: Children's Oncology Group

Sex: All

Age: 2 - 18

Code: NCT05711667

Phase3, Recruiting

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

for
Untreated, Unresectable, or Metastatic Colorectal Cancer
Location: Shirley NY, Sherbrooke, Mineola NY, Lake Success NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07221357

Phase2, Phase3, Recruiting

A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia

for
Severe Hypertriglyceridemia
Location: Worcester MA, Hamden CT, Chicoutimi, New York NY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07269210

Phase2, Recruiting

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

for
Glioblastoma
Location: Providence RI, Lebanon NH, Valhalla NY, Neptune City NJ,
Sponsor: GT Medical Technologies, Inc.

Sex: All

Age: 18+

Code: NCT07195591

Phase3, Recruiting

Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy

for
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma
Location: Baltimore MD, Charlottesville VA, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07003295

Phase2, Recruiting

Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

for
EGFR Mutation Positive Non-small Cell Lung Cancer,
Location: Calverton MD, Fairfax VA, Pittsburgh PA, Houston TX,
Sponsor: Nuvectis Pharma, Inc.

Sex: All

Age: 18+

Code: NCT07315113

Phase1, Recruiting

Human Milk Oligosaccharide-Based Synbiotic Supplement for Intestinal Microbiota Dysbiosis

for
Healthy Volunteers
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 18 - 70+

Code: NCT06615986

Early_phase1, Recruiting

Phase 1 Study of CLR 125 in Triple Negative Breast Cancer

for
Breast Cancer
Location: Princeton NJ, Glen Burnie MD, Jacksonville FL,
Sponsor: Cellectar Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07311993

Phase1, Recruiting

Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)

for
Common Warts, Common Warts (Verruca Vulgaris),
Location: Hunt Valley MD, Saint Augustine FL, Plainfield IN,
Sponsor: Verrica Pharmaceuticals Inc.

Sex: All

Age: 2+

Code: NCT07246590

Phase3, Recruiting

A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)

for
Pneumococcal Infection
Location: Columbia MD, East Syracuse NY, Charlottesville VA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 1

Code: NCT07300267

Phase1, Recruiting

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

for
Small Cell Lung Cancer (SCLC),
Location: Boston MA, New Haven CT, Baltimore MD, Fairfax VA,
Sponsor: Phanes Therapeutics

Sex: All

Age: 18+

Code: NCT05652686

Phase1, Phase2, Recruiting

Using the Smart Underwear Device to Determine a Baseline of Flatus Activity Normalized to Fiber Intake

for
All Health Backgrounds to Determine a Baseline of Flatus Activity,
Location: College Park MD
Sponsor: University of Maryland, College Park

Sex: All

Age: 18+

Code: NCT07134543

Recruiting

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants

for
Healthy Participants
Location: Baltimore MD, Glendale CA
Sponsor: AstraZeneca

Sex: All

Age: 18 - 55

Code: NCT07290283

Phase1, Recruiting

Rocket Study: A Study to Characterize Biomarkers and Disease Progression in Participants With Pelizaeus-Merzbacher Disease

for
Pelizaeus-Merzbacher Disease
Location: Philadelphia PA, Baltimore MD, Atlanta GA
Sponsor: Ionis Pharmaceuticals, Inc.

Sex: Male

Age: 0 - 17

Code: NCT05659901

Recruiting

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

for
Epithelial Ovarian Cancer
Location: Burlington MA, Towson MD, Washington D.C. DC,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT07218809

Phase3, Recruiting

Popular cities in Maryland

AnnapolisBethesdaBaltimoreRockville